Lazar Dimitrov

Lazar Dimitrov is a seasoned professional in corporate development and business strategy within the biotechnology sector, currently serving as a Corporate Development Advisor at Adjuvia Therapeutics, Inc. Since September 2023. Prior to this role, Lazar held significant positions including Senior Vice President of Corporate Development at Bright Peak Therapeutics, where notable achievements included co-leading a $90M Series C fundraising and securing critical licensing agreements. Lazar’s extensive experience also encompasses roles as Vice President of Business Development at Day One Biopharmaceuticals, Principal at The Blackstone Group and Clarus Ventures, and Analyst roles at Rho Ventures and Merrill Lynch. Lazar's academic credentials include a Ph.D. in Genome Sciences from the University of Washington and a bachelor's degree in Economics and Mathematics from Dartmouth College.